Advertisement

BioChip Journal

, Volume 12, Issue 3, pp 222–230 | Cite as

Dexamethasone Leads to Upregulation of BMP6 and ACHE Suppression of SMAD3 and ESR1 Genes in Human Mesenchymal Stem Cells

  • Bo-Bae Kim
  • Minji Kim
  • Yun-Hee Park
  • Jun-Beom Park
Original Article

Abstract

The purpose of this study is to evaluate the effects of dexamethasone on mesenchymal stem cells from human gingiva using next-generation sequencing. The verification and suggestion of possible mechanisms was performed. Human gingiva-derived stem cells were treated with a final concentration of 10-7M dexamethasone at 2 and 24 hours. Extraction of RNA, sequencing of mRNA, gene ontology and pathway analysis were performed. Quantification by real-time polymerase chain reaction was conducted for validation. A fold change of two was applied for this study, and a log2 normalized read count of 5 or greater was applied to minimize false counts. Expression of SMAD3 and ESR1 was decreased in dexamethasone at 24 hours. Increased expression of BMP6 and ACHE was noted in dexamethasone at 24 hours. TGF-β signaling was involved in the target genes chosen for osteoblast differentiation. It was clear that the application of dexamethasone produced reduced expression of SMAD3 and ESR1 and enhanced expression of ACHE and BMP6 of human gingiva-derived mesenchymal stem cells. An RNA sequencing strategy can provide new insights into the mechanism of dexamethasone in stem cells originating from dental areas.

Keywords

Cell differentiation Dexamethasone Gingival Messenger RNA Stem cells Transforming growth factor beta 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Li, T., Li, H., Fan, J., Zhao, R.C. & Weng, X. MicroRNA expression profile of dexamethasone-induced human bone marrow-derived mesenchymal stem cells during osteogenic differentiation. J. Cell. Biochem. 115, 1683–1691 (2014).CrossRefGoogle Scholar
  2. 2.
    Ishida, Y. & Heersche, J.N. Glucocorticoid-induced osteoporosis: both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuate osteoblast differentiation. J. Bone Miner. Res. 13, 1822–1826 (1998).CrossRefGoogle Scholar
  3. 3.
    Atmani, H., Chappard, D. & Basle, M.F. Proliferation and differentiation of osteoblasts and adipocytes in rat bone marrow stromal cell cultures: effects of dexamethasone and calcitriol. J. Cell. Biochem. 89, 364–372 (2003).CrossRefGoogle Scholar
  4. 4.
    Coelho, M.J. & Fernandes, M.H. Human bone cell cultures in biocompatibility testing. Part II: effect of ascorbic acid, beta-glycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials 21, 1095–1102 (2000).Google Scholar
  5. 5.
    Park, J.B. Effects of the combination of dexamethasone and fibroblast growth factor2 on differentiation of osteoprecursor cells. Mol. Med. Rep. 9, 659–662 (2014).CrossRefGoogle Scholar
  6. 6.
    Park, J.B. The effects of dexamethasone, ascorbic acid, and beta-glycerophosphate on osteoblastic differentiation by regulating estrogen receptor and osteopontin expression. J. Surg. Res. 173, 99–104 (2012).CrossRefGoogle Scholar
  7. 7.
    Roelen, B.A. & Dijke, P. Controlling mesenchymal stem cell differentiation by TGFBeta family members. J. Orthop. Sci. 8, 740–748 (2003).CrossRefGoogle Scholar
  8. 8.
    AC’t Hoen, P. et al. Reproducibility of high-throughput mRNA and small RNA sequencing across laboratories. Nat. Biotechnol. 31, 1015–1022 (2013).CrossRefGoogle Scholar
  9. 9.
    Schuster, S.C. Next-generation sequencing transforms today’s biology. Nat. Methods 5, 16–18 (2008).CrossRefGoogle Scholar
  10. 10.
    Misra, K. & Matise, M.P. A critical role for sFRP proteins in maintaining caudal neural tube closure in mice via inhibition of BMP signaling. Dev. Biol. 337, 74–83 (2010).CrossRefGoogle Scholar
  11. 11.
    Jin, Y.R., Turcotte, T.J., Crocker, A.L., Han, X.H. & Yoon, J.K. The canonical Wnt signaling activator, Rspondin2, regulates craniofacial patterning and morphogenesis within the branchial arch through ectodermal-mesenchymal interaction. Dev. Biol. 352, 1–13 (2011).CrossRefGoogle Scholar
  12. 12.
    Beloti, M.M. & Rosa, A.L. Osteoblast differentiation of human bone marrow cells under continuous and discontinuous treatment with dexamethasone. Braz. Dent. J. 16, 156–161 (2005).CrossRefGoogle Scholar
  13. 13.
    Jin, S.H. et al. Isolation and characterization of human mesenchymal stem cells from gingival connective tissue. J. Periodontal. Res. 50, 461–467 (2015).CrossRefGoogle Scholar
  14. 14.
    Kim, B.B., Ko, Y. & Park, J.B. Effects of risedronate on the morphology and viability of gingiva-derived mesenchymal stem cells. Biomed Rep. 3, 845–848 (2015).CrossRefGoogle Scholar
  15. 15.
    Ha, D.H. et al. Potential differentiation ability of gingiva originated human mesenchymal stem cell in the presence of tacrolimus. Sci. Rep. 6, 34910 (2016).CrossRefGoogle Scholar
  16. 16.
    Jeong, S.H., Lee, J.E., Jin, S.H., Ko, Y. & Park, J.B. Effects of Asiasari radix on the morphology and viability of mesenchymal stem cells derived from the gingiva. Mol. Med. Rep. 10, 3315–3319 (2014).CrossRefGoogle Scholar
  17. 17.
    Fournier, B.P., Larjava, H. & Hakkinen, L. Gingiva as a source of stem cells with therapeutic potential. Stem Cells Dev. 22, 3157–3177 (2013).CrossRefGoogle Scholar
  18. 18.
    Jeong, S.H., Kim, B.B., Lee, J.E., Ko, Y. & Park, J.B. Evaluation of the effects of Angelicae dahuricae radix on the morphology and viability of mesenchymal stem cells. Mol. Med. Rep. 12, 1556–1560 (2015).CrossRefGoogle Scholar
  19. 19.
    Lee, S.I., Yeo, S.I., Kim, B.B., Ko, Y. & Park, J.B. Formation of size-controllable spheroids using gingiva-derived stem cells and concave microwells: Morphology and viability tests. Biomed Rep. 4, 97–101 (2016).CrossRefGoogle Scholar
  20. 20.
    Ha, D.H., Yong, C.S., Kim, J.O., Jeong, J.H. & Park, J.B. Effects of tacrolimus on morphology, proliferation and differentiation of mesenchymal stem cells derived from gingiva tissue. Mol. Med. Rep. 14, 69–76 (2016).CrossRefGoogle Scholar
  21. 21.
    Maher, C.A. et al. Transcriptome sequencing to detect gene fusions in cancer. Nature 458, 97–101 (2009).CrossRefGoogle Scholar
  22. 22.
    Nahm, K.Y. et al. Gene profiling of bone around orthodontic mini-implants by RNA-sequencing analysis. Biomed Res. Int. 2015, 538080 (2015).CrossRefGoogle Scholar
  23. 23.
    Jaager, K., Islam, S., Zajac, P., Linnarsson, S. & Neuman, T. RNA-seq analysis reveals different dynamics of differentiation of human dermis-and adipose-derived stromal stem cells. PLoS One 7, e38833 (2012).CrossRefGoogle Scholar
  24. 24.
    Yang, Y. et al. Identification of differentially expressed genes in the development of osteosarcoma using RNAseq. Oncotarget 7, 87194–87205 (2016).Google Scholar
  25. 25.
    Zhou, S. TGF-β regulates β-catenin signaling and osteoblast differentiation in human mesenchymal stem cells. J. Cell. Biochem. 112, 1651–1660 (2011).CrossRefGoogle Scholar
  26. 26.
    Chen, G., Deng, C. & Li, Y.-P. TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int. J. Biol. Sci. 8, 272–288 (2012).CrossRefGoogle Scholar
  27. 27.
    Hjelmeland, A.B., Schilling, S.H., Guo, X., Quarles, D. & Wang, X.-F. Loss of Smad3-mediated negative regulation of Runx2 activity leads to an alteration in cell fate determination. Mol. Cell. Biol. 25, 9460–9468 (2005).CrossRefGoogle Scholar
  28. 28.
    Kaji, H., Naito, J., Sowa, H., Sugimoto, T. & Chihara, K. Smad3 differently affects osteoblast differentiation depending upon its differentiation stage. Horm. Metab. Res. 38, 740–745 (2006).CrossRefGoogle Scholar
  29. 29.
    Matsuda, T., Yamamoto, T., Muraguchi, A. & Saatcioglu, F. Cross-talk between transforming growth factor-β and estrogen receptor signaling through Smad3. J. Biol. Chem. 276, 42908–42914 (2001).CrossRefGoogle Scholar
  30. 30.
    Friedman, M.S., Long, M.W. & Hankenson, K.D. Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. J. Biol. Chem. 98, 538–554 (2006).Google Scholar
  31. 31.
    Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45, D353–D361 (2017).CrossRefGoogle Scholar

Copyright information

© The Korean BioChip Society and Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Bo-Bae Kim
    • 1
  • Minji Kim
    • 1
  • Yun-Hee Park
    • 2
  • Jun-Beom Park
    • 1
  1. 1.Department of Periodontics, College of MedicineThe Catholic University of KoreaSeoulRepublic of Korea
  2. 2.ebiogenSeoulRepublic of Korea

Personalised recommendations